Cirrus Logic Deemed Safe Haven and 4 Stock Analyses to Know Now

Alkermes, Inc. (NASDAQ:ALKS): Current price $22.33

Following the 20% rise over the past few months and given the company’s wholly-owned late-stage assets such as ALKS-9070 for schizophrenia, Citigroup said that there is a substantial amount of further value to be recognized in shares of Alkermes, Inc.  The firm raised their price target for shares from $27 to $30 and keeps a Buy rating on the stock.


Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!